326 related articles for article (PubMed ID: 23475626)
21. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
22. Transfemoral aortic valve implantation new criteria to predict vascular complications.
Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
[TBL] [Abstract][Full Text] [Related]
23. A new technique for vascular access management in transcatheter aortic valve implantation.
Sharp AS; Michev I; Maisano F; Taramasso M; Godino C; Latib A; Denti P; Dorigo E; Giacomini A; Iaci G; Manca M; Ielasi A; Montorfano M; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2010 Apr; 75(5):784-93. PubMed ID: 20049970
[TBL] [Abstract][Full Text] [Related]
24. Collagen plug-based vascular closure devices do not decrease vascular and bleeding complications occurring after balloon aortic valvuloplasty.
Leclercq F; Delseny D; Gervasoni R; Lattuca B; Roubille F; Cayla G; Macia JC
Arch Cardiovasc Dis; 2015 Apr; 108(4):250-7. PubMed ID: 25754907
[TBL] [Abstract][Full Text] [Related]
25. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
Spitzer SG; Wilbring M; Alexiou K; Stumpf J; Kappert U; Matschke K
Catheter Cardiovasc Interv; 2016 Aug; 88(2):E52-8. PubMed ID: 26708225
[TBL] [Abstract][Full Text] [Related]
26. Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis.
Sedaghat A; von Dobbeler C; Sontag B; Sinning JM; Fimmers R; Mellert F; Schiller W; Welz A; Grube E; Nickenig G; Hauptmann KE; Werner N
EuroIntervention; 2015 Oct; 11(6):698-704. PubMed ID: 25631370
[TBL] [Abstract][Full Text] [Related]
27. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation.
Conradi L; Seiffert M; Shimamura K; Schirmer J; Blankenberg S; Reichenspurner H; Diemert P; Treede H
Thorac Cardiovasc Surg; 2014 Sep; 62(6):498-502. PubMed ID: 24911901
[TBL] [Abstract][Full Text] [Related]
28. Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patients.
Santarpino G; Pfeiffer S; Jessl J; Dell'Aquila AM; Pollari F; Pauschinger M; Fischlein T
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):561-7. PubMed ID: 24280712
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation.
Bernelli C; Chieffo A; Montorfano M; Maisano F; Giustino G; Buchanan GL; Chan J; Costopoulos C; Latib A; Figini F; De Meo E; Giannini F; Covello RD; Gerli C; Franco A; Agricola E; Spagnolo P; Cioni M; Alfieri O; Camici PG; Colombo A
JACC Cardiovasc Interv; 2014 Feb; 7(2):140-151. PubMed ID: 24556092
[TBL] [Abstract][Full Text] [Related]
30. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
31. Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center.
Griese DP; Reents W; Kerber S; Diegeler A; Babin-Ebell J
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E726-33. PubMed ID: 23765631
[TBL] [Abstract][Full Text] [Related]
32. In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions.
Nuis RJ; Piazza N; Van Mieghem NM; Otten AM; Tzikas A; Schultz CJ; van der Boon R; van Geuns RJ; van Domburg RT; Koudstaal PJ; Kappetein AP; Serruys PW; de Jaegere PP
Catheter Cardiovasc Interv; 2011 Sep; 78(3):457-67. PubMed ID: 21563291
[TBL] [Abstract][Full Text] [Related]
33. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
Sedaghat A; Sinning JM; Werner N
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients.
Millán X; Azzalini L; Khan R; Cournoyer D; Dorval JF; Ibrahim R; Bonan R; Asgar AW
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1145-1152. PubMed ID: 27029571
[TBL] [Abstract][Full Text] [Related]
35. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications.
Toggweiler S; Leipsic J; Binder RK; Freeman M; Barbanti M; Heijmen RH; Wood DA; Webb JG
JACC Cardiovasc Interv; 2013 Aug; 6(8):767-76. PubMed ID: 23968697
[TBL] [Abstract][Full Text] [Related]
36. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access.
Petronio AS; De Carlo M; Bedogni F; Maisano F; Ettori F; Klugmann S; Poli A; Marzocchi A; Santoro G; Napodano M; Ussia GP; Giannini C; Brambilla N; Colombo A
J Am Coll Cardiol; 2012 Aug; 60(6):502-7. PubMed ID: 22726631
[TBL] [Abstract][Full Text] [Related]
37. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Closure Failure following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
Lee CH; Ko YG; Park Y; Shim CY; Hong GR; Lee SH; Lee S; Jung HW; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
Ann Vasc Surg; 2020 Jul; 66():406-414. PubMed ID: 31918036
[TBL] [Abstract][Full Text] [Related]
39. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
40. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB
Eur Heart J; 2012 Oct; 33(19):2403-18. PubMed ID: 23026477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
